A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation?

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Consciousness may emerge not from code, but from the way living brains physically compute.

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Respondents to an annual Michigan college survey of overused and misused words and phrases say “6-7” is “cooked” and should ...

How can you take a holistic look at computing, from the top down? Computer science is the answer. As the trend toward globalization connects people in every part of the world, digital networks and ...

Today's AI agents are a primitive approximation of what agents are meant to be. True agentic AI requires serious advances in reinforcement learning and complex memory.